Movement Disorders

Phase II study of ANX005 in patients with Huntington’s disease 3:49
Phase II study of ANX005 in patients with Huntington’s disease
Ann Morgan et al. • 16 Sep 2022
Early identification of suboptimal PD control to improve care 0:59
Early identification of suboptimal PD control to improve care
Eric Freire-Alvarez • 15 Sep 2022
fMRI and gait analysis characteristics as biomarkers for alpha-synucleinopathies 2:33
fMRI and gait analysis characteristics as biomarkers for alpha-synucleinopathies
Elisabetta Sarasso • 15 Sep 2022
Movement disorders diagnosis: the classic phenotypes 1:27
Movement disorders diagnosis: the classic phenotypes
Kailash Bhatia • 16 Sep 2022
Overlap between functional neurological disorders and PD 3:48
Overlap between functional neurological disorders and PD
Alberto Espay • 16 Sep 2022
High-quality education to improve quality of care of people with movement disorders 3:51
High-quality education to improve quality of care of people with movement disorders
Francisco Cardoso • 15 Sep 2022
Digital tools in Huntington’s disease clinical trials 1:50
Digital tools in Huntington’s disease clinical trials
Patrick Weydt • 23 Sep 2022
Wellness and holistic health in Parkinson’s disease 2:30
Wellness and holistic health in Parkinson’s disease
K. Ray-Chaudhuri • 17 Sep 2022
Exploratory delayed-start analysis of PASADENA in early-stage Parkinson’s disease 1:43
Exploratory delayed-start analysis of PASADENA in early-stage Parkinson’s disease
Gennaro Pagano • 17 Sep 2022
Innate and adaptive immunity in Parkinson’s disease 1:39
Innate and adaptive immunity in Parkinson’s disease
Marina Romero-Ramos • 17 Sep 2022
COVID-19 and movement disorders 3:54
COVID-19 and movement disorders
Susanne Schneider • 21 Sep 2022
Measuring medication adherence in Parkinson’s disease: PD-MAS 7:07
Measuring medication adherence in Parkinson’s disease: PD-MAS
Michelle Tosin • 23 Sep 2022
Ambulosono: multi-domain exercise training in Parkinson’s disease 10:08
Ambulosono: multi-domain exercise training in Parkinson’s disease
Bin Hu • 12 Sep 2022
The treatment of OFF episodes in Parkinson’s disease 1:33
The treatment of OFF episodes in Parkinson’s disease
Fabrizio Stocchi • 16 Sep 2022
The classification of hyperkinetic movement disorders 3:04
The classification of hyperkinetic movement disorders
Sanjay Pandey • 16 Sep 2022
Blood biomarkers and their association with non-motor symptoms in early Parkinson’s disease 2:49
Blood biomarkers and their association with non-motor symptoms in early Parkinson’s disease
Jaslovleen Kaur • 17 Sep 2022
The content of VJNeurology is intended for healthcare professionals